NCT06629207Recruiting
Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder
Artificial Intelligence on Molecular Imaging to Predict the Risks of Parkinson's Disease for Patients With Rapid Eye Movement Sleep Behavior Disorder
Source: ClinicalTrials.gov · Last updated 8 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study aims to systematically document the course of REM sleep behavior disorder (RBD) and investigate possible clinical and imaging biomarkers for disease progression and conversion risk to Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). The study will use artificial intelligence to analyze imaging and develop a reliable method to predict and stratify patients approaching conversion to overt a-synucleinopathy. Participants will be clinically evaluated and 2 imaging procedures will be done.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 4 Oct 2024
- Start date
- 7 Oct 2024
- Primary completion date
- 1 Aug 2026
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Diseases
- Lewy body dementia, Parkinson disease
- NCT number
- NCT06629207
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 7 Oct 2024 to the primary completion date, 1 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known diagnosis of PD or other neurodegenerative disorder
Other
- Unequivocal signs of parkinsonism on examination
- Narcolepsy or other known causes of RBD
- Moderate to severe obstructive sleep apnea
- Abnormal neurological or MRI examination
Who the study is looking for
- Confirmed clinical iRBD diagnosis by movement disorder specialists according to the International Classification of Sleep Disorders
- Written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Inselspital, University Clinic for Nuclear Medicine Coordinator of this site? Confirm its status | Bern | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.